Mechanism of bone destruction due to Rheumatoid Arthritis in the fields of Osteoimmunology

骨免疫学领域类风湿关节炎引起的骨破坏机制

基本信息

  • 批准号:
    15390637
  • 负责人:
  • 金额:
    $ 9.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Receptor activator of NF-kB ligand (RANKL) is known to be a key molecule of the osteoimmunology. The aim of this study was to analyze the effect of cell transfer of dedritic cells (DCs) stimulated with RANKL on the development of autoimmune arthropathy in MRL/lpr mice, and to evaluate the possible relationship between autoimmune responses and RANKL-mediated osteoclastogenesis. Matured bone marrow DC (BMDC) from MRL/lpr mice were stimulated with RANKL and chick type II collagen (CII), and were subcutaneously transferred one or three times into MRL/lpr mice. Acceleration of autoimmune arthritis with bone destruction was observed in RANKL/CII DC-transferred mice compared with the legions of non-transferred and non-pulsed DC-transferred, CII DC-transferred MRL/lpr mice. A significant shift to memory phenotypes of T cells was detected in RANKL/CII DC-transferred mice. It was shown that the expressions of MHC class II and RANKL-associated molecules including TRAF6, c-Fms, c-Fos, PU.1 c-Src, of the DCs from RANKL/CII DC-transferred mice were significantly upregulated. In addition, the bone marrow culture from RANKL/CII DC-transferred mice resulted in the increases of osteoclast formation and bone resorption, compared with those of non-DC-transferred mice. On the other hand, three times of transfer of RANKL/CII DC into MRL/lpr mice protected the development of autoimmune arthritis, and reduced the splenomegaly and lymphadenopathy through upregulation of Activation-induced cell death (AICD) of peripheral T cells. These results indicate that RANKL pathway plays a crucial role for immunomodulation of autoimmune arthropathy in a murine model for rheumatoid arthritis.
核因子-κ B受体激活因子配体(RANKL)是骨免疫学的关键分子。本研究旨在分析RANKL刺激的树突状细胞(DCs)细胞转移对MRL/lpr小鼠自身免疫性关节病发展的影响,并评估自身免疫反应与RANKL介导的破骨细胞生成之间的可能关系。用RANKL和鸡II型胶原(CII)刺激来自MRL/lpr小鼠的成熟骨髓DC(BMDC),并将其皮下转移至MRL/lpr小鼠中一次或三次。与大量非转移和非脉冲DC转移、CII DC转移MRL/lpr小鼠相比,在RANKL/CII DC转移小鼠中观察到自身免疫性关节炎伴骨破坏加速。在RANKL/CII DC转移小鼠中检测到T细胞记忆表型的显著变化。结果表明,RANKL/CII DC转染小鼠DC的MHC II类分子和RANKL相关分子TRAF 6、c-Fms、c-Fos、PU.1、c-Src的表达显著上调。此外,RANKL/CII DC转移小鼠的骨髓培养物导致破骨细胞形成和骨吸收增加,与非DC转移小鼠相比。另一方面,将RANKL/CII DC三次转移到MRL/lpr小鼠中保护自身免疫性关节炎的发展,并通过上调外周T细胞的活化诱导细胞死亡(AICD)来减少脾肿大和淋巴结病。这些结果表明,RANKL途径在类风湿性关节炎小鼠模型中对自身免疫性关节病的免疫调节起着至关重要的作用。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A soluble form fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as ah efficient inhibitor for the enhanced osteoblastic differentiation ca used by FGFR2 activation in Apert syndrome.
具有 S252W 突变的可溶性成纤维细胞生长因子受体 2 (FGFR2) 可以作为阿佩尔综合征中 FGFR2 激活增强成骨细胞分化的有效抑制剂。
Volume identification of promoter regions involved in cell-and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland, -An analysis of transgenic mice.
参与骨、肾、胎盘和乳腺中细胞和发育阶段特异性骨桥蛋白表达的启动子区域的体积鉴定,-转基因小鼠的分析。
Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with RANKL-Mediated Osteoclastogenesis.
雌激素缺乏会加速与 RANKL 介导的破骨细胞生成相关的小鼠自身免疫性关节炎。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoneda T;Izawa T;Moriyama K;Hayashi Y;et al.
  • 通讯作者:
    et al.
Yoneda T, Moriyama K, Hayashi Y., et al.: "Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with RANKL-Mediated Osteoclastogenesis"Endocrinology. (in press).
Yoneda T、Moriyama K、Hayashi Y. 等人:“雌激素缺乏加速与 RANKL 介导的破骨细胞生成相关的小鼠自身免疫性关节炎”内分泌学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
  • DOI:
    10.1182/blood-2003-11-3839
  • 发表时间:
    2004-10-15
  • 期刊:
  • 影响因子:
    20.3
  • 作者:
    Abe, M;Hiura, K;Matsumoto, T
  • 通讯作者:
    Matsumoto, T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORIYAMA Keiji其他文献

MORIYAMA Keiji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORIYAMA Keiji', 18)}}的其他基金

Elucidation of etiology of facial asymmetry based on integrated genome-phenome analysis
基于综合基因组-表型分析阐明面部不对称的病因
  • 批准号:
    19H03857
  • 财政年份:
    2019
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
International comparative study on craniofacial morphology of Mongolian adolescents
蒙古族青少年颅面形态的国际比较研究
  • 批准号:
    25305037
  • 财政年份:
    2013
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of new technology for controlling suture remodeling using magnetized liposome with liposome
脂质体磁化脂质体控制缝线重塑新技术的开发
  • 批准号:
    23659963
  • 财政年份:
    2011
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of new therapeutic strategy for the craniosynostosis patients
颅缝早闭患者新治疗策略的开发
  • 批准号:
    23390471
  • 财政年份:
    2011
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic study for developing new therapies and its practical use for craniofacial anomalies
颅面异常新疗法开发及其实际应用的基础研究
  • 批准号:
    18209060
  • 财政年份:
    2006
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
The function of periostin during periodontal tissue remodeling caused by mechanical stress.
骨膜素在机械应力引起的牙周组织重塑过程中的功能。
  • 批准号:
    13470452
  • 财政年份:
    2001
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Establishment of new treatment for cleft lip and palate patients-basic research for the application of in vitro hybrid artificial bone-
唇腭裂患者新疗法的建立——体外混合型人工骨应用基础研究——
  • 批准号:
    12557185
  • 财政年份:
    2000
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
REGULATION OF OSTEOCLASTIC BONE RESORPTION BY RHO
RHO 对破骨性骨吸收的调节
  • 批准号:
    11694283
  • 财政年份:
    1999
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
The Role of MAP Kinase in The Signal Transduction Pathways Activated by Mechanical Stress in Mesenchymal Cells.
MAP 激酶在间充质细胞机械应力激活的信号转导途径中的作用。
  • 批准号:
    09672094
  • 财政年份:
    1997
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Estrogen/NDRG2/Na+/K+-ATPase调控通路在唾液生成和雌激素缺乏诱发口干症中的作用研究
  • 批准号:
    81100764
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Estrogen modulation of the lateral habenula and its ability to inhibit midbrain dopamine neurons
雌激素对外侧缰核的调节及其抑制中脑多巴胺神经元的能力
  • 批准号:
    10588333
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Manipulating normal estrogen physiology as a therapeutic approach in cancer
操纵正常雌激素生理学作为癌症的治疗方法
  • 批准号:
    10561945
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Mechanisms of estrogen receptor ligand signaling
雌激素受体配体信号传导机制
  • 批准号:
    10681785
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
  • 批准号:
    10604611
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Research on safety and efficacy evaluation focusing on estrogen-like action of health food materials and components
以保健食品原料及成分雌激素样作用为重点的安全性和功效评价研究
  • 批准号:
    23K10974
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of action of antiestrogens in breast cancer: roles of ubiquitin-like modifications in transcriptional inactivation of Estrogen Receptor alpha.
抗雌激素在乳腺癌中的作用机制:泛素样修饰在雌激素受体α转录失活中的作用。
  • 批准号:
    480045
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Operating Grants
Estrogen receptor signaling, inflammation and ozone toxicity
雌激素受体信号传导、炎症和臭氧毒性
  • 批准号:
    10775945
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
  • 批准号:
    10607151
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer
探索雌激素受体阴性乳腺癌免疫预防的新策略
  • 批准号:
    10583390
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma
开发用于治疗胶质母细胞瘤的有效雌激素受体β激动剂
  • 批准号:
    10594832
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了